Telemedicine as a tool to mitigate cardiometabolic risk associated with serious mental illness

Abstract

People with serious mental illness suffer from substantially higher rates of cardiometabolic morbidity and mortality than the general population. We have evaluated the efficacy of telemedicine for providing cardiometabolic risk management services compared to in-person care. A retrospective chart review was conducted in order to compare changes in body mass index (BMI), systolic blood pressure and serum triglycerides before and after telemedicine (n = 38). The comparator group (n = 38) was selected from a list of all clients who had a conventional appointment at the metabolic clinic. Analysis of Variance showed an overall effect of treatment on BMI (P < 0.001), but no significant differences between the groups on BMI (P = 0.89), systolic blood pressure (P = 0.62) or fasting serum triglycerides (P = 0.81). This suggests that telemedicine may be as effective as in-person care and that telemedicine has the potential to improve access to cardiometabolic risk management services for people with serious mental illness.